Safety of Extended Pirtobrutinib Exposure in Relapsed and/or Refractory B-Cell Malignancies.
Saved in:
| Title: | Safety of Extended Pirtobrutinib Exposure in Relapsed and/or Refractory B-Cell Malignancies. |
|---|---|
| Authors: | Roeker LE; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Coombs CC; Department of Medicine, University of California Irvine Health, Orange, California, USA., Shah NN; Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Jurczak W; Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland., Woyach JA; The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA., Cheah CY; Linear Clinical Research and Sir Charles Gairdner Hospital, Perth, Washington, Australia., Patel K; Center for Blood Disorders and Cellular Therapy, Swedish Cancer Institute, Seattle, Washington, USA., Maddocks K; The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA., Wang Y; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA., Zinzani PL; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia Seràgnoli, Bologna, Italy.; Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna, Italy., Munir T; Department of Haematology, St. James's University Hospital, Leeds, UK., Koh Y; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea., Thompson MC; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Muehlenbein CE; Loxo@Lilly, Indianapolis, Indiana, USA., Wang C; Eli Lilly and Company, Indianapolis, Indiana, USA., Sizelove R; Eli Lilly and Company, Indianapolis, Indiana, USA., Abhyankar S; Eli Lilly and Company, Indianapolis, Indiana, USA., Hasanabba S; Eli Lilly and Company, Indianapolis, Indiana, USA., Tsai DE; Loxo@Lilly, Indianapolis, Indiana, USA., Eyre TA; Oxford University Hospitals NHS Foundation Trust, Churchill Cancer Center, Oxford, UK., Wang M; MD Anderson Cancer Center, Houston, Texas, USA. |
| Source: | Acta haematologica [Acta Haematol] 2025; Vol. 148 (2), pp. 180-197. Date of Electronic Publication: 2024 Jun 05. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Karger Country of Publication: Switzerland NLM ID: 0141053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1421-9662 (Electronic) Linking ISSN: 00015792 NLM ISO Abbreviation: Acta Haematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1421-9662 |
|---|---|
| DOI: | 10.1159/000539587 |
